USPTO serial 79340655
SEER HOME
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 17, 2024
- Examiner
- AURAND, KYLE C
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SEER HOME?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
AU
AU
AU
AU
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
CHARLES G. ZUG
CHARLES G. ZUG NELSON MULLINS RILEY & SCARBOROUGH LLP301 SOUTH COLLEGE STREETSUITE 2300, IP DEPARTMENTCHARLOTTE, NC 28202Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer programs for medical purposes for diagnosis, monitoring, management and treatment of neurological conditions; downloadable computer programs for health purposes for diagnosis, monitoring, management and treatment of neurological conditions; downloadable computer application software for use in the provision of and access to medical treatment for neurological conditions; downloadable computer application software for the provision of medical and health information for use in body monitoring, namely, the management of epilepsy, heart and sleep disorders; downloadable computer application software for the recording, collection, organisation, management and transmission of medical and health information for diagnostic body monitoring relating to neurological and cardiac conditions and sleep disorders; downloadable software for use with medical devices for diagnosis, monitoring, management and treatment of neurological conditions; downloadable software for use with medical diagnostic devices for diagnosis, monitoring, management and treatment of neurological conditions; downloadable software for use with health monitoring devices for diagnosis, monitoring, management and treatment of neurological conditions; downloadable software for use in the treatment of epilepsy for monitoring and diagnosing neurological diseases; downloadable software for use in the management of epilepsy for monitoring and diagnosing neurological diseases; downloadable electronic publications in the nature of scientific and medical research journal articles in the field of medical treatment for epilepsy, cardiac, and sleep disorders and for providing information to patients and doctors in relation to epilepsy and other neurological and cardiac conditions and the diagnosis, monitoring, management and treatment thereof; downloadable computer database programs relating to diagnostic medical and health information for body monitoring for the management of epilepsy, heart and sleep disorders; none of the foregoing in relation to reagents, software or hardware for the analysis of proteins, proteomes, or biological data, and goods and services in the fields of biomolecules, metabolomics, lipidomics, genomics, epigenomics, proteomics, transcriptomics, and secretomics | ACTIVE | — |
| 042 | Software as a service (SAAS) services featuring software for medical purposes for diagnosis, monitoring, management and treatment of neurological conditions; software as a service (SAAS) services featuring software for health purposes for diagnosis, monitoring, management and treatment of neurological conditions; software as a service (SAAS) services featuring software for use in the medical treatment of epilepsy for monitoring and diagnosing neurological diseases, cardiac conditions, and sleep disorders; software as a service (SAAS) services featuring software, namely, providing online non-downloadable computer database programs for enabling the provision of diagnostic medical and health information for use in body monitoring including the management of epilepsy, heart and sleep disorders; software as a service (SAAS) services featuring software for the recording, collection, organisation, management and transmission of medical and health information for diagnostic body monitoring for the management of epilepsy, cardiac and sleep disorders; software as a service (SAAS) services featuring software for use with medical devices for diagnosis, monitoring, management and treatment of neurological conditions; software as a service (SAAS) services featuring software for use with medical diagnostic devices for diagnosis, monitoring, management and treatment of neurological conditions; software as a service (SAAS) services featuring software for use with health monitoring devices for diagnosis, monitoring, management and treatment of neurological conditions; software as a service (SAAS) services featuring software for use in the treatment of epilepsy for monitoring and diagnosing neurological diseases; software as a service (SAAS) services featuring software for use in the management of epilepsy for monitoring and diagnosing neurological diseases; none of the foregoing in relation to reagents, software or hardware for the analysis of proteins, proteomes, or biological data, and goods and services in the fields of biomolecules, metabolomics, lipidomics, genomics, epigenomics, proteomics, transcriptomics, and secretomics | ACTIVE | — |
| 044 | Advisory services relating to medical problems; advisory services relating to medical services; health care consultancy services, namely, consulting services in the field of medical care; medical advisory services; medical analysis services relating to the treatment of patients; medical assistance; medical care services; medical counselling; medical testing and medical analysis services, all for diagnostic purposes; medical information retrieval services, namely medical information provided to medical professionals and patients from remote locations via the Internet and global computer networks through the use of archived medical images and a data storage and retrieval system; medical services; all of the foregoing in relation to the diagnosis, monitoring, management and treatment of epilepsy, neurological conditions, cardiac conditions, and sleep disorders; none of the foregoing in relation to reagents, software or hardware for the analysis of proteins, proteomes, or biological data, and goods and services in the fields of biomolecules, metabolomics, lipidomics, genomics, epigenomics, proteomics, transcriptomics, and secretomics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Seer Medical Holdings Limited
- Other trademarks owned by Seer Medical Holdings Limited
- Other trademarks owned by Seer Medical Pty Ltd
- Other trademarks owned by Seer Medical Pty Ltd
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SEER HOME
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 7, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 19, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 19, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| May 19, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Mar 17, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 17, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 17, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 21, 2024 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Oct 11, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 8, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 8, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 18, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 3, 2024 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Sep 3, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 3, 2024 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Aug 30, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 26, 2024 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Aug 20, 2024 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Nov 12, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 25, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 25, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 13, 2023 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Sep 13, 2023 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| May 4, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 4, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 4, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 4, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 4, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 13, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 13, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 13, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 4, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 3, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 3, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 23, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 3, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 3, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 15, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 14, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 13, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| May 24, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 20, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 19, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |